Ironwood Pharmaceuticals (IRWD) Work In Process (2016 - 2019)
Ironwood Pharmaceuticals' (IRWD) quarterly Work In Process came in at $392000.0 in Q4 2019, down 44.55% quarter-over-quarter from $707000.0 in Q3 2019.
Powered by 
Analysis
Ironwood Pharmaceuticals (IRWD) Work In Process (2016 - 2019) Analysis & Trends
Ironwood Pharmaceuticals has disclosed Work In Process across 2 years of filings, most recently posting $392000.0 for Q4 2019.
- In Q4 2019, Work In Process changed N/A year-over-year to $392000.0; the TTM figure through Dec 2019 stood at $392000.0 (changed N/A YoY), while the FY2019 annual figure was $392000.0, changed N/A from the prior year.
- Work In Process came in at $392000.0 for Q4 2019 at Ironwood Pharmaceuticals, down from $707000.0 in the prior quarter.
- In the past five years, Work In Process ranged from a high of $707000.0 in Q3 2019 to a low of $71000.0 in Q4 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Ironwood Pharmaceuticals | 669.13 Mn | 590.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 392,000.00 |
| Sep 30, 2019 | 707,000.00 |
| Jun 30, 2019 | 260,000.00 |
| Dec 31, 2016 | 71,000.00 |